Van ECK Associates Corp Boosts Stock Position in Astera Labs, Inc. $ALAB

Van ECK Associates Corp lifted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 20.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,237,961 shares of the company’s stock after buying an additional 373,545 shares during the quarter. Astera Labs makes up approximately 0.7% of Van ECK Associates Corp’s investment portfolio, making the stock its 26th largest position. Van ECK Associates Corp owned approximately 1.29% of Astera Labs worth $1,080,980,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Nissay Asset Management Corp Japan lifted its position in shares of Astera Labs by 79.6% during the 2nd quarter. Nissay Asset Management Corp Japan now owns 105,965 shares of the company’s stock valued at $51,183,000 after buying an additional 46,952 shares in the last quarter. Wellington Management Group LLP increased its holdings in Astera Labs by 151.5% in the 2nd quarter. Wellington Management Group LLP now owns 248,914 shares of the company’s stock worth $120,230,000 after acquiring an additional 149,951 shares in the last quarter. Archer Investment Corp purchased a new stake in Astera Labs in the 2nd quarter worth $30,000. Kingsview Wealth Management LLC purchased a new stake in Astera Labs in the 2nd quarter worth $2,553,000. Finally, Beacon Pointe Advisors LLC acquired a new position in Astera Labs during the second quarter worth $653,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Stock Down 4.8%

Shares of NASDAQ ALAB opened at $289.47 on Friday. The firm has a 50-day simple moving average of $342.38 and a 200-day simple moving average of $249.65. The stock has a market capitalization of $50.22 billion, a price-to-earnings ratio of 143.30 and a beta of 3.84. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the prior year, the firm earned $0.44 EPS. Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, equities research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analysts Set New Price Targets

ALAB has been the topic of several recent analyst reports. Barclays increased their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Needham & Company LLC boosted their target price on shares of Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Stifel Nicolaus upped their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 11th. Finally, Morgan Stanley lifted their price objective on Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $340.53.

Insider Activity at Astera Labs

In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 419,244 shares of company stock valued at $163,135,169 in the last three months. Company insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.